ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Sevilla, AN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Syndrome
Chronic Myelomonocytic Leukemia

Acute Myeloid Leukemia (AML) trials near Sevilla, AN, ESP:

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

will be evaluated in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML). The main study has ...

Enrolling
Acute Leukemia of Ambiguous Lineage
Mixed Phenotype Acute Leukemia
Drug: Ziftomenib
Drug: Itraconazole

Phase 1, Phase 2

Kura Oncology

Sevilla, Spain and 55 other locations

when administered to adult patients with relapsed or refractory acute myeloid leukemia (AML) or relapsed or progr...

Active, not recruiting
Acute Myeloid Leukemia (AML)
High-risk Myelodysplastic Syndrome
Drug: RVU120

Phase 2

Ryvu Therapeutics

Sevilla, Spain and 40 other locations

to placebo and VEN+AZA alone for the treatment of participants with Acute Myeloid Leukemia (AML) with a mutation ...

Enrolling
Leukemia, Myeloid, Acute
Drug: Venetoclax (VEN)
Drug: Azacitidine (AZA)

Phase 3

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Seville, Spain and 169 other locations

of JNJ-90189892 in participants with relapsed or refractory (R/R) acute myeloid leukemia (AML) or R/R higher-risk...

Enrolling
Leukemia, Myeloid, Acute
Myelodysplastic Neoplasms
Drug: JNJ-90189892

Phase 1

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Seville, Spain and 7 other locations

combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute...

Enrolling
Leukemia
Drug: Quizartinib
Drug: Placebo

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Seville, Spain and 275 other locations

administered in combination with venetoclax to adult patients with acute myeloid leukemia (AML) who are relapsed ...

Enrolling
Acute Myeloid Leukemia
Drug: Venetoclax
Drug: RVU120

Phase 2

Ryvu Therapeutics

Sevilla, Spain and 36 other locations

monotherapy and in combination with azacitidine in participants with acute myeloid leukemia (AML) and myelodyspla...

Enrolling
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Drug: BGB-11417
Drug: Azacitidine

Phase 1, Phase 2

BeiGene
BeiGene

Seville, Spain and 50 other locations

with intensive chemotherapy in participants with newly diagnosed acute myeloid leukemia (AML) harboring alteratio...

Enrolling
Acute Myeloid Leukemias
Drug: SNDX-5613
Drug: Chemotherapy Regimen

Phase 1

Syndax Pharmaceuticals
Syndax Pharmaceuticals

Sevilla, Spain and 36 other locations

available therapy (BAT) on overall survival (OS) in subjects with acute myeloid leukemia (AML) who are in second ...

Active, not recruiting
Acute Myeloid Leukemia
Other: Observation
Other: Montanide

Phase 3

Sellas Life Sciences

Seville, Spain and 72 other locations

standard of care treatments for patients with relapsed/refractory acute myeloid leukemia will be examined with the followi...

Enrolling
AML
Leukemia, Myeloid, Acute
Drug: Gilteritinib
Biological: Granulocyte colony-stimulating factor

Phase 1

Kura Oncology

Seville, Spain and 42 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems